Stay updated on Adjunctive Obicetrapib in Statin Therapy Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Obicetrapib in Statin Therapy Clinical Trial page.

Latest updates to the Adjunctive Obicetrapib in Statin Therapy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study record history shows a new revision entry (v3.6.5) replacing the prior revision (v3.6.4). This reflects an update to the page version in the record.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision label, v3.6.4, appears in the study's history alongside the previous v3.6.3, indicating an additional update to the record.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded a new revision entry 'v3.6.3' to the study record history, replacing the previous 'v3.6.2'. This reflects a software release/version update to the page rather than changes to the study data.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history, and the previous entry v3.6.0 was removed. This indicates an update to the version history on the ClinicalTrials.gov page.SummaryDifference0.1%

- Check74 days agoChange DetectedThe history update shows recruitment status changed to no longer looking for participants, signaling enrollment has ended or paused. It also adds revision v3.6.0 and removes v3.5.5 from the record’s version history.SummaryDifference0.4%

- Check81 days agoChange DetectedThe study record history now includes a new revision entry labeled v3.5.5, and the previous entry v3.5.4 was removed. This represents an update to the page's revision tracking within ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to Adjunctive Obicetrapib in Statin Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Obicetrapib in Statin Therapy Clinical Trial page.